Acquired hemophilia A: emerging treatment options

References

• CollinsPWManagement of acquired haemophilia AJ Thromb Haemost20119Suppl 122623521781259
   PubMed Web of Science ®Google Scholar
• CohenAJKesslerCMAcquired inhibitorsBaillieres Clin Haematol1996923313548800509
   PubMed Web of Science ®Google Scholar
• ToschiVBaudoFDiagnosis, laboratory aspects and management of acquired hemophilia AIntern Emerg Med20105432533320407848
   PubMed Web of Science ®Google Scholar
• MaADCarrizosaDAcquired factor VIII inhibitors: pathophysiology and treatmentHematology Am Soc Hematol Educ Program200643243717124095
   PubMedGoogle Scholar
• CollinsPWHirschSBaglinTPUK Haemophilia Centre Doctors’ OrganisationAcquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors’ OrganisationBlood200710951870187717047148
   PubMed Web of Science ®Google Scholar
• GreenDLechnerKA survey of 215 non-hemophilic patients with inhibitors to Factor VIIIThromb Haemost19814532002036792737
   PubMed Web of Science ®Google Scholar
• DelgadoJJimenez-YusteVHernandez-NavarroFVillarAAcquired haemophilia: review and meta-analysis focused on therapy and prognostic factorsBr J Haematol20031211213512670328
   PubMed Web of Science ®Google Scholar
• KnoeblPMarcoPBaudoFEACH2 Registry ContributorsDemographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)J Thromb Haemost201210462263122321904
   PubMed Web of Science ®Google Scholar
• BorgJYGuilletBLe Cam-DuchezVGoudemandJLévesqueHSACHA Study GroupOutcome of acquired haemophilia in France: the prospective SACHA (Surveillance des Auto antiCorps au cours de l’Hémophilie Acquise) registryHaemophilia201319456457023574453
   PubMed Web of Science ®Google Scholar
• WebertKEAcquired hemophilia ASemin Thromb Hemost201238773574122941793
   PubMed Web of Science ®Google Scholar
• CoppolaAFavaloroEJTufanoADi MinnoMNCerboneAMFranchiniMAcquired inhibitors of coagulation factors: part I-acquired hemophilia ASemin Thromb Hemost201238543344622740182
   PubMed Web of Science ®Google Scholar
• SrivastavaABrewerAKMauser-BunschotenEPTreatment Guidelines Working Group on Behalf of The World Federation of HemophiliaGuidelines for the management of hemophiliaHaemophilia2013191e1e4722776238
   PubMed Web of Science ®Google Scholar
• CollinsPBaudoFHuth-KühneAConsensus recommendations for the diagnosis and treatment of acquired hemophilia ABMC Res Notes2010316120529258
   PubMedGoogle Scholar
• W CollinsPChalmersEHartDUnited Kingdom Haemophilia Centre Doctors’ OrganizationDiagnosis and management of acquired coagulation inhibitors: a guideline from UKHCDOBr J Haematol2013162675877323889317
   PubMed Web of Science ®Google Scholar
• Huth-KühneABaudoFCollinsPInternational recommendations on the diagnosis and treatment of patients with acquired hemophilia AHaematologica200994456657519336751
   PubMed Web of Science ®Google Scholar
• CollinsPWTreatment of acquired hemophilia AJ Thromb Haemost20075589390017461924
   PubMed Web of Science ®Google Scholar
• ShettySBhaveMGhoshKAcquired hemophilia a: diagnosis, aetiology, clinical spectrum and treatment optionsAutoimmun Rev201110631131621115138
   PubMed Web of Science ®Google Scholar
• SborovDWRodgersGMAcquired hemophilia a: a current review of autoantibody diseaseClin Adv Hematol Oncol2012101192722398803
   PubMedGoogle Scholar
• CollinsPWTherapeutic challenges in acquired factor VIII deficiencyHematology Am Soc Hematol Educ Program2012201236937423233606
   PubMed Web of Science ®Google Scholar
• FranchiniMPostpartum acquired factor VIII inhibitorsAm J Hematol2006811076877316868941
   PubMed Web of Science ®Google Scholar
• ZeitlerHGoldmannGMarquardtNUlrich-MerzenichGLong term outcome of patients with acquired haemophilia – a monocentre interim analysis of 82 patientsAtheroscler Suppl201314122322823357169
   PubMed Web of Science ®Google Scholar
• TurecekPLVáradiKGritschHSchwarzHPFEIBA: mode of actionHaemophilia200410Suppl 23915385040
   PubMed Web of Science ®Google Scholar
• HoffmanMMonroeDM3rdThe action of high-dose factor VIIa (FVIIa) in a cell-based model of hemostasisDis Mon2003491142112525825
   PubMed Web of Science ®Google Scholar
• VáradiKNegrierCBerntorpEMonitoring the bioavailability of FEIBA with a thrombin generation assayJ Thromb Haemost20031112374238014629472
   PubMed Web of Science ®Google Scholar
• VillarAAronisSMorfiniMPharmacokinetics of activated recombinant coagulation factor VII (NovoSeven) in children vs adults with haemophilia AHaemophilia200410435235915230949
   PubMed Web of Science ®Google Scholar
• BaudoFCollinsPHuth-KühneAEACH2 registry contributorsManagement of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) RegistryBlood20121201394622618709
   PubMed Web of Science ®Google Scholar
• AstermarkJDonfieldSMDiMicheleDMFENOC Study GroupA randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) StudyBlood2007109254655116990605
   PubMed Web of Science ®Google Scholar
• HolmströmMTranHTHolmePACombined treatment with APCC (FEIBA®) and tranexamic acid in patients with haemophilia A with inhibitors and in patients with acquired haemophilia A – a two-centre experienceHaemophilia201218454454922348384
   PubMed Web of Science ®Google Scholar
• AledortLMComparative thrombotic event incidence after infusion of recombinant factor VIIa versus factor VIII inhibitor bypass activityJ Thromb Haemost20042101700170815456478
   PubMed Web of Science ®Google Scholar
• EhrlichHJHenzlMJGompertsEDSafety of factor VIII inhibitor bypass activity (FEIBA): 10-year compilation of thrombotic adverse eventsHaemophilia200282839011952842
   PubMed Web of Science ®Google Scholar
• O’ConnellKAWoodJJWiseRPLozierJNBraunMMThromboembolic adverse events after use of recombinant human coagulation factor VIIaJAMA2006295329329816418464
   PubMed Web of Science ®Google Scholar
• SchneidermanJRubinENugentDJYoungGSequential therapy with activated prothrombin complex concentrates and recombinant FVIIa in patients with severe haemophilia and inhibitors: update of our previous experienceHaemophilia20071324424817498072
   PubMed Web of Science ®Google Scholar
• DehmelHWerwitzkeSTrummerAGanserATiedeAThrombelastographic monitoring of recombinant factor VIIa in acquired haemophiliaHaemophilia200814473674218445011
   PubMed Web of Science ®Google Scholar
• HayCRPorcine factor VIII: past, present and futureHaematologica20008510 Suppl2124 discussion 24–2511187865
   PubMedGoogle Scholar
• MorrisonAELudlamCAKesslerCUse of porcine factor VIII in the treatment of patients with acquired hemophiliaBlood1993816151315208453098
   PubMed Web of Science ®Google Scholar
• GiangrandePLPorcine factor VIIIHaemophilia201218330530922531020
   PubMed Web of Science ®Google Scholar
• OBIZUR [prescribing information]Westlake Village, CABaxter Healthcare Corporation2014
   Google Scholar
• MutoAYoshihashiKTakedaMAnti-factor IXa/X bispecific antibody ACE910 prevents spontaneous joint bleeds in a long-term primate model of acquired hemophilia ABlood2014124203165317125274508
   PubMed Web of Science ®Google Scholar
• MannKGJennyRJKrishnaswamySCofactor proteins in the assembly and expression of blood clotting enzyme complexesAnnu Rev Biochem1988579159563052293
   PubMed Web of Science ®Google Scholar
• NesheimMETaswellJBMannKGThe contribution of bovine Factor V and Factor Va to the activity of prothrombinaseJ Biol Chem1979254211095210962500617
   PubMed Web of Science ®Google Scholar
• von DrygalskiACramerTJBhatVGriffinJHGaleAJMosnierLOImproved hemostasis in hemophilia mice by means of an engineered factor Va mutantJ Thromb Haemost201412336337224818532
   PubMed Web of Science ®Google Scholar
• GaleAJXuXPellequerJLGetzoffEDGriffinJHInterdomain engineered disulfide bond permitting elucidation of mechanisms of inactivation of coagulation factor Va by activated protein CProtein Sci20021192091210112192065
   PubMed Web of Science ®Google Scholar
• von DrygalskiABhatVGaleAJGriffinJHMosnierLOSynergism of augmented FVa activity and recombinant human FVIIa represent a novel bypassing strategy in hemophilic patients with inhibitorsHaemophilia201420Suppl 34142
   Google Scholar
• HayCRAcquired haemophiliaBaillieres Clin Haematol199811228730310097808
   PubMed Web of Science ®Google Scholar
• LianECLarcadaAFChiuAYCombination immunosuppressive therapy after factor VIII infusion for acquired factor VIII inhibitorAnn Intern Med1989110107747782496636
   PubMed Web of Science ®Google Scholar
• BaudoFCaimiTde CataldoFDiagnosis and treatment of acquired haemophiliaHaemophilia20101610210210620536992
   PubMed Web of Science ®Google Scholar
• CollinsPBaudoFKnoeblPEACH2 registry collaboratorsImmunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)Blood20121201475522517903
   PubMed Web of Science ®Google Scholar
• GreenDRademakerAWBriëtEA prospective, randomized trial of prednisone and cyclophosphamide in the treatment of patients with factor VIII autoantibodiesThromb Haemost19937057537578128430
   PubMed Web of Science ®Google Scholar
• BittingRLBentSLiYKohlwesJThe prognosis and treatment of acquired hemophilia: a systematic review and meta-analysisBlood Coagul Fibrinolysis200920751752319644360
   PubMed Web of Science ®Google Scholar